Do Hospitals Drug Test Babies at Birth?

Evidence-based answer reviewed against SAMHSA cutoffs and FDA assay documentation · Updated August 2026

Quick answer: Yes — selectively. Hospitals test newborns when prenatal records show risk factors (no prenatal care, prior CPS involvement, maternal self-report, unexplained placental abruption), and every state mandates reporting positive newborn toxicology.

What they test

Meconium (first stool) captures drug exposure across the final two trimesters; umbilical cord tissue increasingly replaces it; neonatal urine reflects only the last few days. Standard newborn panels cover opioids, cocaine, amphetamines, PCP, marijuana and sometimes benzodiazepines/barbiturates.

State-by-state reality

No federal rule forces universal testing — policies range from universal-screening hospitals (some urban systems) to strict risk-based protocols. Roughly half of states treat positive newborn toxicology as automatic CPS referral evidence; several (e.g., Minnesota) require disclosure to mothers.

Mothers get tested too

Maternal urine at admission plus sometimes meconium-matching cord testing; a mother's positive typically triggers both her chart flags and newborn testing regardless of symptoms.

Certified labs nationwide · Results in 1–2 days

Need a test? Order online, test same-day →
Medical disclaimer: DrugPanels provides educational information about laboratory drug testing and does not offer medical advice, diagnosis, or treatment. Detection windows are population ranges — individual results vary with metabolism, dose, frequency and health status. Never stop prescribed medication to pass a test without talking to your prescriber. Affiliate disclosure: some links on this page are affiliate links; if you order through them we may earn a commission at no additional cost to you.

People also ask

Do prescriptions count against me?

No — verified prescriptions report as negative through the Medical Review Officer. Declare medications at collection and answer the follow-up call.

Sources & further reading

  • SAMHSA — Mandatory Guidelines for Federal Workplace Drug Testing Programs (cutoffs, MRO process)
  • DOT — 49 CFR Part 40 procedures for transportation workplace testing
  • Brahm NC et al., Mayo Clinic Proceedings 2008;83(1):66–76 — false-positive cross-reactivity reference
  • FDA — drug-of-abuse test device labeling (detection window conventions)